These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8305340)

  • 1. Prostate cancer: pelvic nodes revisited--sites, incidence and prospects for treatment with radiotherapy.
    Neal AJ; Dearnaley DP
    Clin Oncol (R Coll Radiol); 1993; 5(5):309-12. PubMed ID: 8305340
    [No Abstract]   [Full Text] [Related]  

  • 2. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage.
    Spratt DE; Vargas HA; Zumsteg ZS; Golia Pernicka JS; Osborne JR; Pei X; Zelefsky MJ
    Eur Urol; 2017 Jan; 71(1):37-43. PubMed ID: 27523595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of elective pelvic radiotherapy in clinically node-negative prostate cancer: a systematic review.
    Dirix P; Joniau S; Van den Bergh L; Isebaert S; Oyen R; Deroose CM; Lerut E; Haustermans K
    Radiother Oncol; 2014 Jan; 110(1):45-54. PubMed ID: 23993400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is pelvic irradiation still justified in the treatment of prostate cancer by exclusive radiotherapy?].
    Chapet O; Quero L; Azria D; Bossi A; Hennequin C; Paparel P
    Cancer Radiother; 2009 Sep; 13(5):416-22. PubMed ID: 19167919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the risk of pelvic node involvement in men with prostate cancer in the contemporary era: change you can believe?: in regard to Yu, et al. (Int J Radiat Oncol Biol Phys in press).
    Hayes M; Roach M
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1598; author reply 1598-9. PubMed ID: 21414516
    [No Abstract]   [Full Text] [Related]  

  • 6. Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients: Treatment Optimization Comparing Intensity Modulated X-rays, Volumetric Modulated Arc Therapy, and Intensity Modulated Proton Therapy.
    Vees H; Dipasquale G; Nouet P; Zilli T; Cozzi L; Miralbell R
    Technol Cancer Res Treat; 2015 Apr; 14(2):181-9. PubMed ID: 24694113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What evidence do we need to support the use of extended pelvic lymph node dissection in prostate cancer?
    Briganti A; Giannarini G; Karnes RJ; Gandaglia G; Ficarra V; Montorsi F
    Eur Urol; 2015 Apr; 67(4):597-8. PubMed ID: 25281390
    [No Abstract]   [Full Text] [Related]  

  • 8. Helical intensity-modulated radiotherapy of the pelvic lymph nodes with a simultaneous integrated boost to the prostate--first results of the PLATIN 1 trial.
    Habl G; Katayama S; Uhl M; Kessel KA; Edler L; Debus J; Herfarth K; Sterzing F
    BMC Cancer; 2015 Nov; 15():868. PubMed ID: 26547188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic lymphadenectomy for the staging of apparently localized prostatic cancer.
    Wilson CS; Dahl DS; Middleton RG
    J Urol; 1977 Feb; 117(2):197-8. PubMed ID: 833967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A plea for surgical lymph node staging in advanced prostate cancer.
    Liedberg F; Ahlgren G; Bratt O; Bendahl PO
    Eur Urol; 2013 Feb; 63(2):409-10. PubMed ID: 23137942
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymph node staging in clinically localized prostate cancer.
    Wawroschek F; Hamm M; Weckermann D; Vogt H; Harzmann R
    Urol Int; 2003; 71(2):129-35. PubMed ID: 12890947
    [No Abstract]   [Full Text] [Related]  

  • 12. Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer.
    Ramey SJ; Agrawal S; Abramowitz MC; Moghanaki D; Pisansky TM; Efstathiou JA; Michalski JM; Spratt DE; Hearn JWD; Koontz BF; Liauw SL; Pollack A; Anscher MS; Den RB; Stephans KL; Zietman AL; Lee WR; Stephenson AJ; Tendulkar RD
    Eur Urol; 2018 Jul; 74(1):99-106. PubMed ID: 29128208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic lymphadenectomy for stage B1 adenocarcinoma or the prostate: justified or not?
    Nicholson TC; Richie JP
    J Urol; 1977 Feb; 117(2):199-201. PubMed ID: 833968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer despite two negative randomized trials.
    Nguyen PL; D'Amico AV
    J Clin Oncol; 2008 Apr; 26(12):2055-6; author reply 2056-7. PubMed ID: 18421061
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphangiography with fine-needle aspiration biopsy of pelvic and abdominal lymph nodes in cancer staging.
    Correa RJ
    Urol Clin North Am; 1982 Feb; 9(1):153-5. PubMed ID: 7080285
    [No Abstract]   [Full Text] [Related]  

  • 16. Ex vivo comparison of radiological and histological evaluation of early metastatic lesions of pelvic lymph nodes from carcinoma of the bladder or prostate.
    Komatsu H; Hayashi S; Tanabe N; Shirasu N; Takihana Y; Takei K; Ishihama T; Tago K; Yamada Y; Ueno A
    J Urol; 1987 Aug; 138(2):341-3. PubMed ID: 3599251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of lymph node counts on the detection of pelvic lymph node metastasis in prostate cancer.
    Barth PJ; Gerharz EW; Ramaswamy A; Riedmiller H
    Pathol Res Pract; 1999; 195(9):633-6. PubMed ID: 10507083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helical tomotherapy with simultaneous integrated boost for high-risk and lymph node-positive prostate cancer: early report on acute and late toxicity.
    Engels B; Soete G; Tournel K; Bral S; De Coninck P; Verellen D; Storme G
    Technol Cancer Res Treat; 2009 Oct; 8(5):353-59. PubMed ID: 19754211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer.
    Thomas T
    Nat Rev Urol; 2023 Apr; 20(4):197. PubMed ID: 36899178
    [No Abstract]   [Full Text] [Related]  

  • 20. Pelvic lymph node dissection for prostate cancer: frequency and distribution of nodal metastases in a contemporary radical prostatectomy series.
    Godoy G; von Bodman C; Chade DC; Dillioglugil O; Eastham JA; Fine SW; Scardino PT; Laudone VP
    J Urol; 2012 Jun; 187(6):2082-6. PubMed ID: 22498221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.